368 related articles for article (PubMed ID: 29485654)
1. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.
Mancini A; Campagna F; Amodio P; Tuohy KM
Food Funct; 2018 Mar; 9(3):1373-1388. PubMed ID: 29485654
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and hepatic encephalopathy.
Dhiman RK
Metab Brain Dis; 2013 Jun; 28(2):321-6. PubMed ID: 23463489
[TBL] [Abstract][Full Text] [Related]
3. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
[TBL] [Abstract][Full Text] [Related]
4. Clinical science workshop: targeting the gut-liver-brain axis.
Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.
Zhu R; Liu L; Zhang G; Dong J; Ren Z; Li Z
Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37279097
[TBL] [Abstract][Full Text] [Related]
6. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
7. What is new about diet in hepatic encephalopathy.
Merli M; Iebba V; Giusto M
Metab Brain Dis; 2016 Dec; 31(6):1289-1294. PubMed ID: 26419384
[TBL] [Abstract][Full Text] [Related]
8. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A
World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640
[TBL] [Abstract][Full Text] [Related]
9. [Advances in host-microbe metabolic axis].
Pi Y; Gao K; Zhu W
Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota: its role in hepatic encephalopathy.
Rai R; Saraswat VA; Dhiman RK
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Vilchez-Vargas R; Vasapolli R; Malfertheiner P
Dig Dis; 2019; 37(2):161-169. PubMed ID: 30428474
[TBL] [Abstract][Full Text] [Related]
12. Linkage of gut microbiome with cognition in hepatic encephalopathy.
Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
[TBL] [Abstract][Full Text] [Related]
13. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.
Saboo K; Shamsaddini A; Iyer MV; Hu C; Fagan A; Gavis EA; White MB; Fuchs M; Heuman DM; Sikaroodi M; Iyer RK; Gillevet PM; Bajaj JS
J Hepatol; 2021 Jan; 74(1):80-88. PubMed ID: 32679299
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.
Garcovich M; Zocco MA; Roccarina D; Ponziani FR; Gasbarrini A
World J Gastroenterol; 2012 Dec; 18(46):6693-700. PubMed ID: 23239905
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
[TBL] [Abstract][Full Text] [Related]
16. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
18. Probiotics in management of hepatic encephalopathy.
Sharma BC; Singh J
Metab Brain Dis; 2016 Dec; 31(6):1295-1301. PubMed ID: 27121846
[TBL] [Abstract][Full Text] [Related]
19. The Link between Gut Microbiota and Hepatic Encephalopathy.
Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
[TBL] [Abstract][Full Text] [Related]
20. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
